Several reports demonstrated that the CypA/CD147 pathway may be involved in the pathology of RA and treatment with anti-CypA antibody resulted in an intense reduction of MMP-9 production, cartilage erosion, and arthritis in the murine collagen-induced arthritis (CIA) model. Here, PPIA is linked to rheumatoid arthritis.